+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Bipolar Disorder - Market Analysis, Trends, and Forecasts

  • ID: 1244802
  • Report
  • 156 Pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Abbvie
  • Allergan Plc
  • Astrazeneca Plc
  • Eli Lilly and Company
  • Glaxosmithkline Plc
  • Janssen Pharmaceutica Nv
  • MORE
The Bipolar Disorder market worldwide is projected to grow by US$848.8 Million, driven by a compounded growth of 2.3%. Mood Stabilizers, one of the segments analyzed and sized in this study, displays the potential to grow at over 1.6%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$608.5 Million by the year 2025, Mood Stabilizers will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 1.9% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$34 Million to the region's size and clout in the next 5 to 6 years. Over US$24.7 Million worth of projected demand in the region will come from the rest of the European markets. In Japan, Mood Stabilizers will reach a market size of US$28.3 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 3.6% over the next couple of years and add approximately US$231.2 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • AbbVie, Inc.
  • Allergan PLC
  • AstraZeneca PLC
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Janssen Pharmaceuticals
  • Novartis International AG
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer, Inc.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbvie
  • Allergan Plc
  • Astrazeneca Plc
  • Eli Lilly and Company
  • Glaxosmithkline Plc
  • Janssen Pharmaceutica Nv
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Bipolar Disorder Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Bipolar Disorder Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Bipolar Disorder Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Bipolar Disorder Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Mood Stabilizers (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 5: Mood Stabilizers (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 6: Mood Stabilizers (Drug Class) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Anticonvulsants (Drug Class) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 8: Anticonvulsants (Drug Class) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 9: Anticonvulsants (Drug Class) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 10: Antipsychotic Drugs (Drug Class) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 11: Antipsychotic Drugs (Drug Class) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 12: Antipsychotic Drugs (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 13: Antidepressant Drugs (Drug Class) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025

TABLE 14: Antidepressant Drugs (Drug Class) Market Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 15: Antidepressant Drugs (Drug Class) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 16: Anti-anxiety Drugs (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 17: Anti-anxiety Drugs (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 18: Anti-anxiety Drugs (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Bipolar Disorder Market Share (in %) by Company: 2019 & 2025

TABLE 19: United States Bipolar Disorder Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025

TABLE 20: Bipolar Disorder Market in the United States by Drug Class: A Historic Review in US$ Million for 2009-2017

TABLE 21: United States Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

JAPAN

TABLE 22: Japanese Market for Bipolar Disorder: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025

TABLE 23: Bipolar Disorder Market in Japan: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017

TABLE 24: Japanese Bipolar Disorder Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

CANADA

TABLE 25: Canadian Bipolar Disorder Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025

TABLE 26: Canadian Bipolar Disorder Historic Market Review by Drug Class in US$ Million: 2009-2017

TABLE 27: Bipolar Disorder Market in Canada: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025

CHINA

TABLE 28: Chinese Bipolar Disorder Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025

TABLE 29: Bipolar Disorder Historic Market Analysis in China in US$ Million by Drug Class: 2009-2017

TABLE 30: Chinese Bipolar Disorder Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025

FRANCE

TABLE 31: Bipolar Disorder Market in France by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 32: French Bipolar Disorder Historic Market Scenario in US$ Million by Drug Class: 2009-2017

TABLE 33: French Bipolar Disorder Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

EUROPE

Market Facts & Figures

European Bipolar Disorder Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 34: European Bipolar Disorder Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 35: Bipolar Disorder Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 36: European Bipolar Disorder Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 37: European Bipolar Disorder Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025

TABLE 38: Bipolar Disorder Market in Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017

TABLE 39: European Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

ITALY

TABLE 40: Italian Bipolar Disorder Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025

TABLE 41: Bipolar Disorder Historic Market Analysis in Italy in US$ Million by Drug Class: 2009-2017

TABLE 42: Italian Bipolar Disorder Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025

GERMANY

TABLE 43: Bipolar Disorder Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025

TABLE 44: German Bipolar Disorder Historic Market Analysis in US$ Million by Drug Class: 2009-2017

TABLE 45: German Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

UNITED KINGDOM

TABLE 46: United Kingdom Market for Bipolar Disorder: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025

TABLE 47: Bipolar Disorder Market in the United Kingdom: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017

TABLE 48: United Kingdom Bipolar Disorder Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

SPAIN

TABLE 49: Spanish Bipolar Disorder Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025

TABLE 50: Spanish Bipolar Disorder Historic Market Review by Drug Class in US$ Million: 2009-2017

TABLE 51: Bipolar Disorder Market in Spain: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025

RUSSIA

TABLE 52: Russian Bipolar Disorder Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025

TABLE 53: Bipolar Disorder Market in Russia by Drug Class: A Historic Review in US$ Million for 2009-2017

TABLE 54: Russian Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 55: Rest of Europe Bipolar Disorder Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025

TABLE 56: Bipolar Disorder Market in Rest of Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017

TABLE 57: Rest of Europe Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 58: Asia-Pacific Bipolar Disorder Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 59: Bipolar Disorder Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017

TABLE 60: Asia-Pacific Bipolar Disorder Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025

TABLE 61: Bipolar Disorder Market in Asia-Pacific by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 62: Asia-Pacific Bipolar Disorder Historic Market Scenario in US$ Million by Drug Class: 2009-2017

TABLE 63: Asia-Pacific Bipolar Disorder Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

AUSTRALIA

TABLE 64: Bipolar Disorder Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025

TABLE 65: Australian Bipolar Disorder Historic Market Analysis in US$ Million by Drug Class: 2009-2017

TABLE 66: Australian Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

INDIA

TABLE 67: Indian Bipolar Disorder Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025

TABLE 68: Indian Bipolar Disorder Historic Market Review by Drug Class in US$ Million: 2009-2017

TABLE 69: Bipolar Disorder Market in India: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025

SOUTH KOREA

TABLE 70: Bipolar Disorder Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025

TABLE 71: South Korean Bipolar Disorder Historic Market Analysis in US$ Million by Drug Class: 2009-2017

TABLE 72: Bipolar Disorder Market Share Distribution in South Korea by Drug Class: 2009 VS 2019 VS 2025

REST OF ASIA-PACIFIC

TABLE 73: Rest of Asia-Pacific Market for Bipolar Disorder: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025

TABLE 74: Bipolar Disorder Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017

TABLE 75: Rest of Asia-Pacific Bipolar Disorder Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

LATIN AMERICA

TABLE 76: Latin American Bipolar Disorder Market Trends by Region/Country in US$ Million: 2018-2025

TABLE 77: Bipolar Disorder Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017

TABLE 78: Latin American Bipolar Disorder Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025

TABLE 79: Latin American Bipolar Disorder Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025

TABLE 80: Bipolar Disorder Historic Market Analysis in Latin America in US$ Million by Drug Class: 2009-2017

TABLE 81: Latin American Bipolar Disorder Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025

ARGENTINA

TABLE 82: Argentinean Bipolar Disorder Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025

TABLE 83: Bipolar Disorder Market in Argentina in US$ Million by Drug Class: A Historic Review for the Period 2009-2017

TABLE 84: Argentinean Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

BRAZIL

TABLE 85: Bipolar Disorder Market in Brazil by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 86: Brazilian Bipolar Disorder Historic Market Scenario in US$ Million by Drug Class: 2009-2017

TABLE 87: Brazilian Bipolar Disorder Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

MEXICO

TABLE 88: Bipolar Disorder Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025

TABLE 89: Mexican Bipolar Disorder Historic Market Analysis in US$ Million by Drug Class: 2009-2017

TABLE 90: Mexican Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

REST OF LATIN AMERICA

TABLE 91: Rest of Latin America Bipolar Disorder Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025

TABLE 92: Bipolar Disorder Market in Rest of Latin America by Drug Class: A Historic Review in US$ Million for 2009-2017

TABLE 93: Rest of Latin America Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

MIDDLE EAST

TABLE 94: The Middle East Bipolar Disorder Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 95: Bipolar Disorder Market in the Middle East by Region/Country in US$ Million: 2009-2017

TABLE 96: The Middle East Bipolar Disorder Market Share Breakdown by Region/Country: 2009, 2019, and 2025

TABLE 97: The Middle East Bipolar Disorder Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025

TABLE 98: The Middle East Bipolar Disorder Historic Market by Drug Class in US$ Million: 2009-2017

TABLE 99: Bipolar Disorder Market in the Middle East: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025

IRAN

TABLE 100: Iranian Market for Bipolar Disorder: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025

TABLE 101: Bipolar Disorder Market in Iran: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017

TABLE 102: Iranian Bipolar Disorder Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

ISRAEL

TABLE 103: Israeli Bipolar Disorder Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025

TABLE 104: Bipolar Disorder Market in Israel in US$ Million by Drug Class: A Historic Review for the Period 2009-2017

TABLE 105: Israeli Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

SAUDI ARABIA

TABLE 106: Saudi Arabian Bipolar Disorder Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025

TABLE 107: Bipolar Disorder Historic Market Analysis in Saudi Arabia in US$ Million by Drug Class: 2009-2017

TABLE 108: Saudi Arabian Bipolar Disorder Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED ARAB EMIRATES

TABLE 109: Bipolar Disorder Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025

TABLE 110: United Arab Emirates Bipolar Disorder Historic Market Analysis in US$ Million by Drug Class: 2009-2017

TABLE 111: Bipolar Disorder Market Share Distribution in United Arab Emirates by Drug Class: 2009 VS 2019 VS 2025

REST OF MIDDLE EAST

TABLE 112: Bipolar Disorder Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025

TABLE 113: Rest of Middle East Bipolar Disorder Historic Market Analysis in US$ Million by Drug Class: 2009-2017

TABLE 114: Rest of Middle East Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

AFRICA

TABLE 115: African Bipolar Disorder Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025

TABLE 116: Bipolar Disorder Market in Africa by Drug Class: A Historic Review in US$ Million for 2009-2017

TABLE 117: African Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

IV. COMPETITION

ABBVIE

ALLERGAN PLC

ASTRAZENECA PLC

ELI LILLY AND COMPANY

GLAXOSMITHKLINE PLC

JANSSEN PHARMACEUTICA NV

NOVARTIS INTERNATIONAL AG

OTSUKA PHARMACEUTICAL

PFIZER

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbvie
  • Allergan Plc
  • Astrazeneca Plc
  • Eli Lilly and Company
  • Glaxosmithkline Plc
  • Janssen Pharmaceutica Nv
  • Novartis International Ag
  • Otsuka Pharmaceutical
  • Pfizer
Note: Product cover images may vary from those shown
Adroll
adroll